Imatinib provides durable molecular and cytogenetic responses in a practical setting for both newly diagnosed and previously treated chronic myelogenous leukemia: a study in Nagasaki prefecture, Japan

✍ Scribed by Emi Matsuo; Yasushi Miyazaki; Chizuko Tsutsumi; Yoriko Inoue; Reishi Yamasaki; Tomoko Hata; Takuya Fukushima; Hideki Tsushima; Daisuke Imanishi; Yoshitaka Imaizumi; Masako Iwanaga; Mari Sakai; Koji Ando; Yasushi Sawayama; Daisuke Ogawa; Yasuhisa Kawaguchi; Kazuhiro Nagai; Kunihiro Tsukasaki; Shuichi Ikeda; Yukiyoshi Moriuchi; Shinichiro Yoshida; Miyuki Honda; Jun Taguchi; Yasuyuki Onimaru; Takeshi Tsuchiya; Masayuki Tawara; Sunao Atogami; Masaomi Yamamura; Hisashi Soda; Yoshiharu Yoshida; Yuji Matsuo; Hiroaki Nonaka; Tatsuro Joh; Yumi Takasaki; Chiyuki Kawasaki; Saburo Momita; Itsuro Jinnai; Kazutaka Kuriyama; Masao Tomonaga

• Book ID: 111835639
• Publisher: Carden Jennings Publishing
• Year: 2007
• Tongue: English
• Weight: 163 KB
• Volume: 85
• Category: Article
• ISSN: 0925-5710
• DOI: 10.1532/ijh97.06157